Nafamostat reduces the incidence of post-ERCP pancreatitis : a systematic review and meta-analysis of randomized controlled trials

Horváth István László and Kleiner Dénes and Nagy Rita and Fehérvári Péter and Hankó Balázs and Hegyi Péter and Csupor Dezső: Nafamostat reduces the incidence of post-ERCP pancreatitis : a systematic review and meta-analysis of randomized controlled trials.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 115 (2). pp. 206-212. ISSN 0009-9236 (2024)

[thumbnail of ClinPharmaandTherapeutics-2023-Horvath-NafamostatReducestheIncidenceofpostERCPPancreatitisASystematic.pdf] Text
ClinPharmaandTherapeutics-2023-Horvath-NafamostatReducestheIncidenceofpostERCPPancreatitisASystematic.pdf - Published Version

Download (1MB)
Item Type: Journal Article
Journal or Publication Title: CLINICAL PHARMACOLOGY & THERAPEUTICS
Date: 2024
Volume: 115
Number: 2
Page Range: pp. 206-212
ISSN: 0009-9236
Faculty/Unit: Faculty of Pharmacy
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 34413258
DOI azonosító: https://doi.org/10.1002/cpt.3118
Date Deposited: 2024. Jan. 24. 09:06
Last Modified: 2024. Jan. 24. 09:06
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/29392

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year